# Obalon in Children With Severe Obesity

> **NCT02137330** · PHASE3 · COMPLETED · sponsor: **Bambino Gesù Hospital and Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Severe Pediatric Obesity (BMI > 97° pc -According to Centers for Disease Control and Prevention BMI Charts-)
- Altered Liver Function Tests
- Glycemic Intolerance

## Interventions

- **DEVICE:** Swallowable Obalon® Gastric Balloon

## Key facts

- **NCT ID:** NCT02137330
- **Lead sponsor:** Bambino Gesù Hospital and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137330, "Obalon in Children With Severe Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02137330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
